520 related articles for article (PubMed ID: 33179141)
1. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
Qu Y; Zhang S; Zhang Y; Feng X; Wang F
Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
[TBL] [Abstract][Full Text] [Related]
2. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
[TBL] [Abstract][Full Text] [Related]
3. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment.
Han W; Huang B; Zhao XY; Shen GL
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786
[TBL] [Abstract][Full Text] [Related]
4. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.
Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y
PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
Li X; Cai Y
Aging (Albany NY); 2020 Aug; 12(16):16457-16475. PubMed ID: 32858528
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
Tian Q; Gao H; Zhao W; Zhou Y; Yang J
Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
[TBL] [Abstract][Full Text] [Related]
7. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma.
Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y
J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
9. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma.
Liu X; Wang J
Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111
[TBL] [Abstract][Full Text] [Related]
10. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response.
Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W
Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an immune and stromal prognostic signature in uveal melanoma to guide clinical therapy.
Gong Q; Wan Q; Li A; Yu Y; Ding X; Lin L; Qi X; Hu L
Aging (Albany NY); 2020 Oct; 12(20):20254-20267. PubMed ID: 33100273
[TBL] [Abstract][Full Text] [Related]
12. A novel immune-related genes prognosis biomarker for melanoma: associated with tumor microenvironment.
Huang R; Mao M; Lu Y; Yu Q; Liao L
Aging (Albany NY); 2020 Apr; 12(8):6966-6980. PubMed ID: 32310824
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma.
Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST
J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462
[TBL] [Abstract][Full Text] [Related]
14. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
Wu M; Wang Z; Zhang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
[TBL] [Abstract][Full Text] [Related]
15. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
16. Gene expression and immune infiltration in melanoma patients with different mutation burden.
Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z
BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of the B Cell-Associated Fc Receptor-like Molecule-Based Prognostic Signature in Skin Cutaneous Melanoma.
Liu Y; Chen Y; Hu X; Meng J; Li X
Biomed Res Int; 2020; 2020():8509805. PubMed ID: 32908921
[TBL] [Abstract][Full Text] [Related]
18. Prognostic signature and immune efficacy of m
Wu XR; Chen Z; Liu Y; Chen ZZ; Tang F; Chen ZZ; Li JJ; Liao JL; Cao K; Chen X; Zhou J
J Cell Mol Med; 2021 Sep; 25(17):8405-8418. PubMed ID: 34288419
[TBL] [Abstract][Full Text] [Related]
19. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
[TBL] [Abstract][Full Text] [Related]
20. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM.
Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y
Front Immunol; 2024; 15():1387316. PubMed ID: 38660305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]